Immunotherapy is not just for melanoma anymore
By Julie Steenhuysen and Deena Beasley CHICAGO/LOS ANGELES (Reuters) - Diagnosed with advanced lung cancer over a year ago, Gabe Tar...
Read More »By Julie Steenhuysen and Deena Beasley CHICAGO/LOS ANGELES (Reuters) - Diagnosed with advanced lung cancer over a year ago, Gabe Tar...
Read More »LONDON (Reuters) - Britain's healthcare cost watchdog NICE is recommending a new eye drug from Bayer and Regeneron, after a price di...
Read More »By Andrew M. Seaman NEW YORK (Reuters Health) - Popular smoking cessation treatments - such as nicotine replacements and antidepress...
Read More »LONDON (Reuters) - There are no benefits from giving patients with severe flu a double dose of Roche's drug Tamiflu, despite calls b...
Read More »(Reuters) - The Food and Drug Administration has for the third time refused approval to Endo Health Solutions Inc's injectable testo...
Read More »By Kerry Grens NEW YORK (Reuters Health) - Tranquilizers known as benzodiazepines and certain older antidepressants are linked with ...
Read More »LONDON (Reuters) - Five top Japanese drug companies are to open their "libraries" of experimental compounds to scrutiny by scientist...
Read More »By Kathryn Doyle NEW YORK (Reuters Health) - They are a fad that refuses to fade, but no solid evidence exists to show whether or no...
Read More »By Genevra Pittman NEW YORK (Reuters Health) - Losing weight may ease psoriasis and improve quality of life for some overweight peop...
Read More »
By Ben Hirschler LONDON (Reuters) - GlaxoSmithKline is betting on a new vaccine technology based on chimpanzee viruses by acquiring ...
Read More »